Visium Technologies, Inc.: 5%+ holders

As of November 10, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Visium Technologies, Inc. The largest reported stake is Dr. Bo Niclas Adler's, at 48.8%. 9 filings are on record since April 24, 2026 (Schedule 13D, November 6, 2026).

Dr. Bo Niclas Adler also filed stake reports on 1 other company ↓

Sell to companies like Visium Technologies, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Your website Find my buyers

Opens in a new tab. No signup.

Key facts

• Filing 2026-11-06 · Reporting person: Dr. Bo Niclas Adler · Sole voting: 0 · Shared voting: 620,000,003 · Sole dispositive: 0 · Shared dispositive: 620,000,003 · SCHEDULE 13D, 2026-11-06
• Filing 2026-11-03 · Reporting person: Mark B. Lucky · Sole voting: 119,243,454 · Shared voting: 503,415 · Sole dispositive: 119,243,454 · Shared dispositive: 503,415 · SCHEDULE 13D/A, 2026-11-03
• Filed 2026-10-29 · Holder: Mark B. Lucky · Percent: 9.43% · SCHEDULE 13D/A
• Filed 2026-10-29 · Holder: Mark B. Lucky · Percent: 9.43% · SCHEDULE 13D/A
• Filing 2026-10-28 · Reporting person: Paul Richard Taylor · Sole voting: 0 · Shared voting: 0 · Sole dispositive: 0 · Shared dispositive: 0 · SCHEDULE 13D/A, 2026-10-28

Visium Technologies, Inc. has 9 Schedule 13D or 13G filings on record since 2026-04-24. 2 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind Visium Technologies, Inc. and the warning signs.

See Visium Technologies, Inc.'s free Snapshot Watch Visium Technologies, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on Visium Technologies, Inc. and the records around it.

Visium Technologies, Inc. elsewhere on the record

• Leadership changes Sep 2026

Companies that share a holder

• Dr. Bo Niclas Adler also filed stake reports on 1 other company: Edgemode, Inc. (Jul 2026)
• Paul Richard Taylor also filed stake reports on 2 other companies: Edgemode, Inc. (Jan 2026)

Want the whole picture on Visium Technologies, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Visium Technologies, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Visium Technologies, Inc. covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   15 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Swipe the table sideways to see every column.

The latest filing identifies Visium Technologies, Inc. by CUSIP 92836G309 and gives its principal executive office as 4094 Majestic Lane, Suite 360, Fairfax, VA 22033 (SCHEDULE 13D, 2026-11-06).

Source of funds (Item 3)

PTSG acquired the securities reported in this statement as follows: (i) under Private Placement Memorandum No. 1 dated March 31, 2026 (subscription agreement dated March 28, 2026), on April 3, 2026, three shares of Series AA Convertible Preferred Stock for $300,000 ($100,000 per share), which the Issuer's records show as issued; (ii) under Private Placement Memorandum No. 2, 500,000,000 shares of Common Stock for $375,000 ($0.00075 per share) on April 3, 2026.Dr. Bo Niclas Adler, SCHEDULE 13D, 2026-11-06

Not applicable. The Series E Preferred Stock and the staff options described in the Original Statement were never issued or granted to the Reporting Person. The Reporting Person acquired no securities of the Issuer and paid no funds or other consideration.Paul Richard Taylor, SCHEDULE 13D/A, 2026-10-28

The beneficial ownership reported in the Original Schedule 13D was acquired in connection with the Reporting Person's appointment as an officer and director of the Issuer and the transactions contemplated by the non-binding letter of intent (the "LOI") with ConnexUS AI. As described in Items 4 and 5 below, that transaction has been terminated and the Reporting Person no longer beneficially owns any shares.Rai Cheddi, SCHEDULE 13D/A, 2026-06-15

Purpose of Transaction (Item 4)

Paul Richard Taylor

The transactions described in the Original Statement did not occur. The Issuer's proposed acquisition of ConnexUS AI Inc. was terminated on June 8, 2026, and no Series E Preferred Stock was issued. The Reporting Person resigned as Chairman, Chief Executive Officer and a director of the Issuer on October 26, 2026. The Reporting Person has no plans or proposals that relate to or would result in any of the matters described in paragraphs (a) through (j) of Item 4 of Schedule 13D.Item 4 of the SCHEDULE 13D/A filed 2026-10-28

Rai Cheddi

The Reporting Person acquired the shares of Common Stock reported in the Original Schedule 13D in connection with his appointment as Chief Operating Officer and Chief Technology Officer of the Issuer and the proposed transactions under the LOI with ConnexUS AI. On or about June 8, 2026, the Issuer and ConnexUS AI entered into a Mutual Release, Settlement, and Termination Agreement (the "Release Agreement") that terminated the LOI in its entirety. Concurrently with the execution of the Release Agreement, the Reporting Person resigned from any and all officer, director, employee, consultant, and other positions with the Issuer, effective immediately. Pursuant to the terms of the Release Agreement and the resignation, the Reporting Person no longer beneficially owns any shares of the Issuer's Common Stock. The Release Agreement provides for mutual general releases of all claims arising out of or relating to the LOI and related matters and confirms that there are no further payment, performance, or other obligations between the parties. The Reporting Person has no present plans or proposals that relate to or would result in any of the actions described in paragraphs (a) through (j) of Item 4 of Schedule 13D, other than the clean termination and resignation described above. The Reporting Person disclaims any continuing beneficial ownership interest in the Issuer.Item 4 of the SCHEDULE 13D/A filed 2026-06-15

Mark B. Lucky

The paragraph of Item 4 captioned "Employment" is amended and restated in its entirety, and a paragraph captioned "Proposed reverse stock split" is added, as follows: Employment. On October 26, 2026, the Reporting Person delivered to the Issuer a notice under Section 4(c) of his Executive Employment Agreement dated March 28, 2026 (the "Employment Agreement") stating that Good Reason exists (the "Notice"). Under the Employment Agreement, the Issuer has 30 days to cure. On November 2, 2026, the Reporting Person delivered to the Issuer, by electronic mail to its counsel, and to Dr. Niclas Adler for PT Smart Green Technologies and Adler Capital Limited, a letter suspending the cure period and the effective date of his resignation for Good Reason until the Issuer's Board of Directors has elected at least one independent director and constituted a committee of independent directors with authority over the Notice. Under the letter, the cure period ends 30 days after that committee is constituted; the Reporting Person may end the suspension at any time after November 25, 2026 by five business days' written notice; the suspension ends immediately if the Issuer terminates his employment, materially reduces his authority, duties or responsibilities, or takes any other action that would itself constitute Good Reason; and, if the matters described in the Notice have not been cured, his resignation for Good Reason takes effect no later than March 1, 2027. If his resignation for Good …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-11-03; the filing has the rest

Dr. Bo Niclas Adler

The Reporting Persons review their investment in the Issuer on a regular and continuing basis. As of the date of this statement, the Reporting Persons have the following plans or proposals of the kinds described in Item 4. None is the subject of a definitive agreement, and each may change or be abandoned. (a) Acquisition or disposition of securities. The Reporting Persons may acquire additional securities of the Issuer, or dispose of securities of the Issuer, from time to time. (b) and (c) Extraordinary transactions and sales of assets. Dr. Adler has discussed with the Issuer possible transactions in which the Issuer would acquire businesses or assets, including businesses in which Dr. Adler has an interest. (d) Board and management. The Reporting Persons have discussed with the Issuer possible changes to the composition of its board of directors. (e) and (g) Capitalization and charter. The Reporting Persons have had no discussions with the Issuer regarding a reverse stock split, changes to its authorized capital, and amendments to, or the elimination of, classes or series of its preferred stock. Except as described above, the Reporting Persons have no present plans or proposals that relate to or would result in any of the matters described in clauses (a) through (j) of Item 4. The Reporting Persons will amend this statement as or if Rule 13d-2 requires.Item 4 of the SCHEDULE 13D filed 2026-11-06

Timeline

Swipe the table sideways to see every column.

Questions about who owns Visium Technologies, Inc.

Who owns Visium Technologies, Inc.?

On this page, 2 holders' latest ownership filings report 5% or more of Visium Technologies, Inc.: Dr. Bo Niclas Adler (48.8%, Schedule 13D, filed 2026-11-06) and Mark B. Lucky (9.43%, Schedule 13D/A, filed 2026-11-03).

Who are the largest shareholders of Visium Technologies, Inc.?

By the share each holder's latest filing reports, the largest holders of Visium Technologies, Inc. on this page are Dr. Bo Niclas Adler (48.8%) and Mark B. Lucky (9.43%).

When did Dr. Bo Niclas Adler buy into Visium Technologies, Inc.?

The filings give report dates, not purchase dates. The earliest filing from Dr. Bo Niclas Adler on this page is the Schedule 13D, filed 2026-11-06, reporting 48.8%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Also on the record for Visium Technologies, Inc.

Swipe the table sideways to see every column.

Tools for this story

Each opens in a new tab, filled in for Visium Technologies, Inc.. With no account yet, you sign up free and land on the result.

• Get an alert when Visium Technologies, Inc. is mentioned again
• Find former Visium Technologies, Inc. employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes